Seeing Is Believing
Currently out of the existing stock ratings of Lisa Walter, 42 are a BUY (87.5%), 6 are a HOLD (12.5%).
Analyst Lisa Walter, currently employed at RBC, carries an average stock price target met ratio of 21.79% that have a potential upside of 12.87% achieved within 46 days.
Lisa Walter’s has documented 95 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 08-Oct-2026.
Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 8/18/2026. The price target of $5 was fulfilled within 6 days with a profit of $0.47 (8.59%) receiving and performance score of 14.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
11 months 5 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
11 months 23 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
11 months 24 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 2 months 9 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 5 months 7 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
Which stock is Lisa Walter most bullish on?
Which stock is Lisa Walter most reserved on?
What Year was the first public recommendation made by Lisa Walter?